COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Income Growth Analysis including revenue, gross profit, operating profit, net profit, EPS, and other financial metrics. Compare income growth against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.

Revenue Growth

-1.23%

Decreased from previous period

Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.

Cost of Revenue Growth

-2.48%

Decreased from previous period

Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.

Gross Profit Growth

4.03%

Decreased from previous period

Growth of 4.03% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

5.33%

Increased from previous period

Margin change of 5.33% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

-100.00%

G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.

Selling & Marketing Expenses Growth

-100.00%

Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.

Other Expenses Growth

-21.39%

Decreased from previous period

Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Operating Expenses Growth

1.78%

Decreased from previous period

Operating expenses change of 1.78% versus flat Healthcare costs. Walter Schloss would verify control.

Total Costs & Expenses Growth

-1.85%

Decreased from previous period

Total costs reduction while Healthcare median is -0.67%. Seth Klarman would investigate advantages.

Interest Expense Growth

-11.76%

Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Depreciation & Amortization Growth

No Data

No Data available this quarter, please select a different quarter.

EBITDA Growth

10.38%

Decreased from previous period

EBITDA change of 10.38% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

11.76%

Increased from previous period

Margin change of 11.76% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

10.30%

Decreased from previous period

Income change of 10.30% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

11.68%

Decreased from previous period

Margin change of 11.68% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

229.13%

Increased from previous period

Other expenses change of 229.13% versus flat Healthcare. Walter Schloss would verify control.

Pre-Tax Income Growth

16.77%

Decreased from previous period

Income change of 16.77% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

18.23%

Increased from previous period

Margin change of 18.23% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

58.01%

Increased from previous period

Tax expense change of 58.01% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

4.09%

Decreased from previous period

Income change of 4.09% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

5.39%

Decreased from previous period

Margin change of 5.39% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

4.08%

Decreased from previous period

EPS change of 4.08% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

4.08%

Decreased from previous period

Diluted EPS change of 4.08% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

-0.00%

Share count reduction while Healthcare median is 0.06%. Seth Klarman would investigate strategy.

Share Count Growth (Diluted)

-0.00%

Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would investigate strategy.

Select Chart Metric:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Revenue Growth

-1.23%

Decreased from previous period

Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.

Cost of Revenue Growth

-2.48%

Decreased from previous period

Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.

Gross Profit Growth

4.03%

Decreased from previous period

Growth of 4.03% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

5.33%

Increased from previous period

Margin change of 5.33% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

-100.00%

G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.

Selling & Marketing Expenses Growth

-100.00%

Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.

Other Expenses Growth

-21.39%

Decreased from previous period

Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Operating Expenses Growth

1.78%

Decreased from previous period

Operating expenses change of 1.78% versus flat Healthcare costs. Walter Schloss would verify control.

Total Costs & Expenses Growth

-1.85%

Decreased from previous period

Total costs reduction while Healthcare median is -0.67%. Seth Klarman would investigate advantages.

Interest Expense Growth

-11.76%

Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Depreciation & Amortization Growth

No Data

No Data available this quarter, please select a different quarter.

EBITDA Growth

10.38%

Decreased from previous period

EBITDA change of 10.38% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

11.76%

Increased from previous period

Margin change of 11.76% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

10.30%

Decreased from previous period

Income change of 10.30% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

11.68%

Decreased from previous period

Margin change of 11.68% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

229.13%

Increased from previous period

Other expenses change of 229.13% versus flat Healthcare. Walter Schloss would verify control.

Pre-Tax Income Growth

16.77%

Decreased from previous period

Income change of 16.77% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

18.23%

Increased from previous period

Margin change of 18.23% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

58.01%

Increased from previous period

Tax expense change of 58.01% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

4.09%

Decreased from previous period

Income change of 4.09% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

5.39%

Decreased from previous period

Margin change of 5.39% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

4.08%

Decreased from previous period

EPS change of 4.08% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

4.08%

Decreased from previous period

Diluted EPS change of 4.08% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

-0.00%

Share count reduction while Healthcare median is 0.06%. Seth Klarman would investigate strategy.

Share Count Growth (Diluted)

-0.00%

Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would investigate strategy.

Select Chart Metric: